Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough

Vaccine

Volumn 21, Issue 17-18, 2003, Pages 1924-1931

  Giammanco, A ^a   Taormina, S ^a   Chiarini, A ^a   Dardanoni, G ^b   Stefanelli, P ^c   Salmaso, S ^c   Mastrantonio, P ^c  

^a UNIVERSITY OF PALERMO   (Italy)

^b Ispettorato Sanitario Regionale   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

IgG subclasses; Immune response; Pertussis toxin; Pertussis vaccines; Th cell polarisation

Indexed keywords

ACELLULAR VACCINE; ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; PERTUSSIS TOXIN; PERTUSSIS VACCINE; TOXIN ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELL POLARITY; CHILD; CONTROLLED STUDY; CONVALESCENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFANT; INFECTION; MAJOR CLINICAL STUDY; NORMAL HUMAN; PERTUSSIS; PRIORITY JOURNAL; RECIPIENT; SERUM; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TH2 CELL; VACCINATION;

EID: 0037449069     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00823-X     Document Type: Article

References (46)

1. Cushley W. Immunoglobulins. In: Collier L, Balows A, Sussman M, editors. Topley & Wilson's microbiology and microbial infections. 9th ed., vol. 3. London: Arnold; 1998. p. 25-36.
2. Morell A., Skvaril F., Hitzig W.H., Barandun S. IgG subclasses: development of the serum concentrations in "normal" infants and children. J. Pediatr. 80:1972;960-964.
3. Schackelford P.G., Granoff D.M., Nahm M.H., Scott M.G., Suarez B., Pandey J.P.et al. Relation of age, race and allotype to immunoglobulin subclass concentrations. Pediatr. Res. 19:1985;846-849.
4. Claesson B.A., Lagergard T., Trollfors B. Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infectios. J. Clin. Microbiol. 26:1988;2549-2553.
5. Freijd A., Hammarstrom L., Persson M.A.A., Smith C.I.E. Plasma anti-pneumococcal antibody activityof the IgG class and subclasses in otitis prone children. Clin. Exp. Immunol. 56:1984;233-238.
6. Rautonen N., Pelkonen J., Sipinen S., Kayhty H., Makela O. Isotype concentrations of human antibodies to group A meningococcal polysaccharide. J. Immunol. 137:1986;2670-2675.
7. Dengrove E.J.L., Heiner D.C., St. Geme J.W. Jr., Leake R., Baraff L.J., Ward J.I. IgG and IgG subclass specific antibody responses to diphtheria and tetanus toxoids in newborns and infants given DPT immunization. Pediatr. Res. 20:1986;735-739.
8. Jertborn M., Svennerholm A.M., Holmgren J. IgG and IgA subclass distribution of antitoxin antibody responses after oral cholera vaccination or cholera disease. Int. Arch. Allergy Appl. Immunol. 85:1988;358-363.
9. Cardoso A.I., Sixt N., Vallier A., Fayolle J., Buckland R., Wild T.F. Measles virus DNA vaccination: antibody isotype is determined by the method of immunisation and by the nature of both the antigen and the communised antigen. J. Virol. 72:1998;2516-2518.
10. Stavnezer J. Immunoglobulin class switching. Curr. Opin. Immunol. 8:1996;199-205.
11. Coffman R.L., Lebman D.A., Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54:1993;229-270.
12. Coffman R.L., Carty J. A T-cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ J. Immunol. 136:1986;949-954.
13. Anam K., Afrin F., Banerjee D., Pramanik N., Guha S.K., Goswami R.P.et al. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients. Clin. Diagn. Lab. Immunol. 6:1999;231-235.
14. Ausiello C.M., Lande R., Urbani F., La Sala A., Stefanelli P., Mastrantonio P.et al. Cell-mediated immune responses in 4-year-old children after primary immunization with acellular pertussis vaccines. Infect. Immun. 67:1999;4064-4071.
15. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A.E., Anemona A.et al. and the Progetto Pertosse Working Group - A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:1996;341-348.
16. Giammanco A, Taormina S, Genovese M, Mangiaracina G, Giammanco G, Chiarini A. Serological responses to infection with B. pertussis. In: Brown F, Greco D, Mastrantonio P, Salmaso S, Wassilak S, editors. Pertussis vaccine trials. Karger: Basel. Dev Biol Stand. 1997;89:213-20.
17. Manclark CR, Meade BD, Burstyn DG. Serological response to Bordetella pertussis. In: Rose NR, Friedman H, Fahey JL, editors. Manual of clinical laboratory immunology. 3rd ed. Washington (DC): American Society for Microbiology; 1986. p. 388-94.
18. Zackrisson G., Lagergard T., Trollfors B. Subclass compositions of Immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine. J. Clin. Microbiol. 27:1989;1567-1571.
19. Pittman M. The concept of pertussis as a toxin-mediated disease. Ped. Infect. Dis. J. 3:1984;467-486.
20. Taranger J., Trolfors B., Lagergård T., Sundh V., Bryla D.A., Schneerson R.et al. Correlation between pertussis toxin IgG antibodies in post vaccination sera and subsequent protection against pertussis. J. Infect. Dis. 181:2000;1010-1013.
21. Zackrisson G., Taranger J., Trollfors B. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. J. Pediatr. 116:1990;190-194.
22. Robbins J.B., Pittman M., Trollfors B., Lagergård T., Taranger J., Schneerson R. Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine. Pediatr. Infect. Dis. J. 12:1993;795-807.
23. Hewlett EL, Cherry JD. New and improved vaccines against pertussis. In: Levine MM, Woodrow GC, Kaper JB, Cobon JS, editors. New generation vaccines. 2nd ed. New York: Marcel Dekker; 1997. p. 387-416.
24. Ad hoc Group for the Study of Pertussis Vaccines - Placebo-controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events. Lancet 1998;i:955-60.
25. Gustafsson L., Hallander H.O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:1996;349-355.
26. van den Berg B.M., Beekhuizen H., Mooi F.R., van Furth R. Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells. Infect. Immun. 67:1999;1050-1055.
27. Storsaeter J., Hallander H.O., Gustafsson L., Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 16:1998;1907-1916.
28. Cherry J.D., Gornbein J., Heininger U., Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine. 16:1998;1901-1906.
29. Ausiello C.M., Urbani F., La Sala A., Lande R., Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:1997;2168-2174.
30. Petersen J.W., Ibsen P.H., Haslov K., Heron I. Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleens of mice aerosol infected with Bordetella pertussis. Infect. Immun. 60:1992;4563.
31. Weiss A.A., Mobberley P.S., Fernandez R.C., Mink C.M. Characterization of human bactericidal antibodies to Bordetella pertussis. Infect. Immun. 67:1999;1424-1431.
32. Mills K.H.G., Ryan M., Ryan E., Mahon B.P. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:1998;594-602.
33. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7:1989;145-173.
34. Kaufmann S.H.E. Immunity to intracellular bacteria. Ann. Rev. Immunol. 11:1993;129-163.
35. Taylor C. Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses. Infect. Immun. 63:1995;3241.
36. Ryan M., Murphy G., Gothefors L., Nillson L., Storsaeter J., Mills K.H.G. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175:1997;1246-1250.
37. Ryan M., Murphy G., Nilsson L., Shackley F., Gothefors L., Omar K.et al. Distinct Th cell subtypes induced with whole-cell and acellular pertussis vaccines in children. Immunol. 93:1998;1-10.
38. Ryan M., Gothefors L., Storsaeter J., Mills K.H.G. B. pertussis specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of T cell cytokine profiles in infants anf mice. Dev. Biol. Stand. 89:1997;251-259.
39. Sewell W.A., Munoz J.J., Vadas M.A. Enhancement of the intensity, persistence and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice. J. Exp. Med. 157:1983;2087-2096.
40. Munoz JJ. Action of pertussigen (Pertussis Toxin) on the host immune system. In: Wardlaw AC, Parton R, editors. Pathogenesis and immunity in Pertussis, Wiley; 1988. p. 173-92.
41. Samore M.H., Siber G.R. Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone. Vaccine. 14:1996;290-297.
42. He Q., Minh N.N.T., Edelman K., Viljanen M.K., Arvilommi H., Mertsola J. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults. Infect. Immun. 66:1998;3796-3801.
43. Torre D., Issi M., Giovanni C., Fiori G.P., Sampietro C. Total serum IgE levels in children with pertussis. Am. J. Dis. Child. 144:1990;290-291.
44. Kaufmann SHE. Cell mediated immunity and intracellular bacterial infections. In: Hausler WJ, Sussman M, editors. Topley & Wilson's microbiology and microbial infections. Bacterial infections. 9th ed., vol. 3. London: Arnold; 1998. p. 47-63.
45. Bromberg K., Tannis G., Steiner P. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect. Immun. 59:1991;4715-4719.
46. Saukkonen K., Cebellos C., Burroughs M., Prasad S., Tuomanen E. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1991;1143-1149.